The global autoimmune disease therapeutics market is anticipated to expand steadily from 2025 to 2035, driven by increasing cases of rheumatoid arthritis, psoriasis, and inflammatory bowel disease.

Artificial intelligence (AI) is entering the mainstream. The term encompasses a wide variety of machines that can learn from ...

Objectives To examine the association between body mass index (BMI) categories and the fragility fractures in Thai men and to ...

Kay, J. and Upchurch, K.S. (2012) ACR/EULAR 2010 Rheumatoid Arthritis Classification Criteria. Rheumatology, ... Epidemiological and Diagnostic Profiles of Chronic Inflammatory Rheumatism in a ...

Background Recently, an American College of Rheumatology (ACR)/European League Against Rheumatism (EULAR) collaboration developed new classification criteria for rheumatoid arthritis (RA). Objective ...

Risk of preventable hospitalization before and after diagnosis among rheumatoid arthritis patients compared to non-rheumatoid arthritis controls. Joint Bone Spine. 2020;87(2):149-156. doi:10.1016 ...

For the estimated 1.5 million Americans living with rheumatoid arthritis and millions more with related autoimmune conditions, this test frequently marks the beginning of their diagnostic journey.

People with rheumatoid arthritis have various treatment options, ranging from methotrexate to biologics to JAK inhibitors. The road to remission isn’t always easy, but more research and tailored ...

Rheumatoid arthritis is the most common type of autoimmune-related arthritis. It’s estimated that about 1.3 million adults in the United States (0.6-1% of the adult population) have RA.

Following clinicians’ implementation of the 2010 ACR criteria, fibromyalgia diagnoses nearly doubled, from 0.58% in 2010 to 0.99% in 2011, then stabilized at approximately 0.80% through 2014. After ...

Rheumatoid arthritis (RA) and lupus both cause joint pain and stiffness. Despite some similarities, it’s easy for doctors to distinguish them. RA has more debilitating effects on the joints ...

As rheumatoid arthritis advances to its second stage, the body increases production of antibodies like rheumatoid factor. The immune system reaction intensifies, causing more persistent symptoms ...